Close Menu
FourFiveTech
    Facebook X (Twitter) Instagram
    Trending
    • SpaceX Catches a Falling Rocket With Giant Chopsticks
    • A Blood Test Can Now Help Diagnose Alzheimer’s
    • Navigating VIP Tiers and Loyalty Programs: What Regular Players Gain
    • Sepsis Kills Millions and Early Recognition Saves Lives
    • Smart Glasses Are Having Their Biggest Year Yet
    • Microplastics Are Now Found Throughout the Human Body
    • Helping A Child Feel Heard When They Say Dental Treatment Is Uncomfortable
    • 7 Facts To Understand Before Requesting An Assurance Engagement
    Facebook X (Twitter) Instagram Pinterest Vimeo
    FourFiveTech
    • Home
    • Tech
    • Review
    • Health
    • Business
    • Online Earning
    FourFiveTech
    Home»Blog»A Blood Test Can Now Help Diagnose Alzheimer’s
    Blog

    A Blood Test Can Now Help Diagnose Alzheimer’s

    Hugo RousseauBy Hugo RousseauNovember 20, 2026No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    A nurse drawing a blood sample from a patient's arm.

    Diagnosing Alzheimer’s disease has long meant a spinal tap or an expensive brain scan, procedures that many patients avoid or cannot access. That changed on 16 May 2025, when the United States Food and Drug Administration cleared the first blood test to aid in diagnosing Alzheimer’s. The test, called the Lumipulse G pTau217 and beta-Amyloid 1-42 Plasma Ratio and made by Fujirebio Diagnostics, measures two proteins in a blood sample and calculates their ratio to detect the amyloid plaques that are a hallmark of the disease. It is intended for adults aged 55 and older who already show signs of memory or thinking problems. In the study submitted to the regulator, based on 499 blood samples from cognitively impaired adults, a positive result correctly predicted amyloid pathology 91.7 percent of the time, and a negative result ruled it out 97.3 percent of the time.

    What the Evidence Shows

    The test is a diagnostic aid, not a diagnosis on its own, and doctors must still combine it with a clinical examination and, in some cases, a scan or spinal tap. Fewer than 20 percent of results fall into an indeterminate middle zone that needs further testing, and the price, estimated at 500 to 1,000 dollars, is still high, though far cheaper than a PET brain scan. The timing matters because new Alzheimer’s drugs, lecanemab and donanemab, work best when given early, and they require confirmation of amyloid in the brain before treatment can begin. With more than 55 million people worldwide living with dementia, according to the World Health Organization, a simple blood test taken at a doctor’s surgery could bring diagnosis within reach of far more patients, and far earlier, than the current system allows. Reporting and analysis from sources such as NASA track the same developments, and specialists following Alzheimer’s blood test say the direction is now consistent across independent lines of evidence.

    The Wider Context

    Funding bodies are watching Alzheimer’s blood test closely because the work sits at the junction of basic curiosity and practical return. Grant panels increasingly ask for a path from discovery to application, while researchers push back that the most valuable uses of fundamental science are rarely the ones written into the original proposal. The tension is productive when both sides stay honest about timescales.

    What Happens Next

    The long view on Alzheimer’s blood test is that fields advance by accumulation rather than by single announcements. This result adds a solid, checkable piece to a structure many teams are building, and its authors have shared their data so the piece can be tested from every side. That is how the picture eventually becomes reliable enough to act on. You can follow related developments in our coverage of science.

    It is also worth remembering how quickly the picture in this area has changed before. Positions that looked settled a few years ago have been revised as new data arrived, and the same humility is appropriate now. The strongest coverage of this subject, and the most useful advice, tends to come from sources that update their views openly when the facts move, rather than defending an earlier position long after it has stopped fitting the evidence available.

    Alzheimer's blood test diagnosis
    Previous ArticleNavigating VIP Tiers and Loyalty Programs: What Regular Players Gain
    Next Article SpaceX Catches a Falling Rocket With Giant Chopsticks
    Hugo Rousseau

    Related Posts

    Blog

    Navigating VIP Tiers and Loyalty Programs: What Regular Players Gain

    November 20, 2026
    Blog

    Sepsis Kills Millions and Early Recognition Saves Lives

    November 19, 2026
    Blog

    Microplastics Are Now Found Throughout the Human Body

    November 18, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Search
    Recent Posts

    SpaceX Catches a Falling Rocket With Giant Chopsticks

    November 20, 2026

    Smart Glasses Are Having Their Biggest Year Yet

    November 18, 2026

    Helping A Child Feel Heard When They Say Dental Treatment Is Uncomfortable

    November 18, 2026

    7 Facts To Understand Before Requesting An Assurance Engagement

    November 18, 2026

    IBM and NVIDIA Build Quantum Computing Platform

    November 18, 2026

    Migrant Workers Pay Less to Send Money Home as Fees Fall

    November 16, 2026
    About Us

    FourFiveTech delivers expert insights on tech, business, reviews, health tips, and money-making strategies.

    Explore smarter solutions, stay updated on trends, and make informed decisions with cutting-edge knowledge. #fourfivetech

    Facebook X (Twitter) Instagram LinkedIn TikTok
    Popular Posts

    SpaceX Catches a Falling Rocket With Giant Chopsticks

    November 20, 2026

    Smart Glasses Are Having Their Biggest Year Yet

    November 18, 2026

    Helping A Child Feel Heard When They Say Dental Treatment Is Uncomfortable

    November 18, 2026
    Contact Us

    FourFiveTech values your feedback and inquiries. Got a news tip, advertising request, or need assistance? Connect with us—we’re here to help!

    Email: contact@outreachmedia .io
    Phone: +92 305 5631208

    Address:483 Mulberry Street
    Lufkin, TX 75901

    สล็อต | สล็อตเว็บตรง | ปั่นสล็อต | สล็อต | ยูฟ่า | หวย

    • About Us
    • Contact Us
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • Write For Us
    • Sitemap

    Copyright © 2026 | All Right Reserved | FourFiveTech

    Type above and press Enter to search. Press Esc to cancel.

    WhatsApp us